載入...
Sequential Treatment Based on Sunitinib and Sorafenib in Patients with Metastatic Renal Cell Carcinoma
Objectives: The aim of our study was to evaluate the outcome of alternative sequences of sunitinib followed by sorafenib versus sorafenib followed by sunitinib therapies in patients with metastatic renal cell carcinoma (mRCC). Materials and Methods: This single-center study analyzed patients with mR...
Na minha lista:
| 發表在: | Cureus |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Cureus
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6516620/ https://ncbi.nlm.nih.gov/pubmed/31131167 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.4244 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|